# SIGA-246 to Treat Smallpox

> **NCT00303225** · PHASE1 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Vaccinia

## Interventions

- **DRUG:** Vaccine: SIGA-246

## Key facts

- **NCT ID:** NCT00303225
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-03-13
- **Primary completion:** —
- **Final completion:** 2006-08-04
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00303225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00303225, "SIGA-246 to Treat Smallpox". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00303225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*